📖

DNA Damage Response in Parkinson's Disease

wiki page Created: 2026-04-02T20:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-dna-damage-response-park
Related Entities
mechanisms-dna-damage-response-parkinsons
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

📊 Evidence Profile
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
151
Outgoing
247
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Linked Artifacts (384)
mentions🔬How do dilncRNAs specifically drive molecular crowding and p75%
mentions🔬What determines the specificity of DDR protein recruitment t75%
mentions🔬Epigenetic reprogramming in aging neurons75%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples70%
mentions🧫Experiment: Multi-Ethnic PD GWAS70%
mentions🧫TDP-43 mitochondrial invasion and DNA release via mPTP70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%
mentions🧫GWAS of plasma pTau217 in East Asian cohort70%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%
mentions🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal70%
mentions🧫Single-cell RNA-seq analysis of mouse testes with gonadal de70%
mentions🧫BDEV injection and recipient microglial transcriptome analys70%
mentions🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 70%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#70%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#70%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%
mentions🧫Viral Infections and Alzheimer's Disease — causal mecha70%
mentions🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto70%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%
mentions🧫TFAM and mtDNA analysis in AKI patients70%
mentions🧫Traumatic Brain Injury and Alzheimer's Disease Relation70%
mentions🧫In vitro DDR reconstitution on nucleosomes70%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and70%
mentions🧫dilncRNA-mediated molecular crowding and phase separation70%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk70%
mentions🧫cGAMP biomarker analysis in ALS patient spinal cord samples70%
mentions🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des70%
mentions🧫mtROS effects on TFAM and mtDNA in HK2 cells70%
mentions🧫IRF1 transcriptional regulation of Nlrc5 and Ciita promoters70%
mentions🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%
mentions🧫Factor depletion effects on DDR focus formation in vivo70%
mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%
mentions🧫Epigenetic clocks association with brain aging patterns in o70%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
mentions🧫Cytochrome Therapeutics70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫DDR factor depletion and focus formation analysis70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
related🧫Macroautophagy Dysfunction in PD - Experiment Design70%
mentions🧫E2F regulation of endocycles in trophoblast giant cells70%
mentions🧫cGAS/STING pathway activation by TDP-43-released mtDNA70%
mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
mentions🧫Antiviral Therapy Trial for Parkinson's Disease70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫Longitudinal TLR2 reporter gene study in α-synuclein mice70%
related🔬What determines the specificity of DDR protein recruitment t67%
related🔬How do dilncRNAs specifically drive molecular crowding and p67%
related🔬Epigenetic reprogramming in aging neurons67%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In65%
related🧪PARP1 Inhibition Therapy65%
related🧪SIRT6-NAD+ Axis Enhancement Therapy65%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa63%
related🧫Cytochrome Therapeutics63%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk63%
related🧫Viral and Post-Infectious Mechanisms in ALS — Experiment Des63%
related🧫Single-cell RNA-seq analysis of mouse testes with gonadal de63%
related🧫TDP-43 mitochondrial invasion and DNA release via mPTP63%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec63%
related🧫s:** - Temporal analysis showing mitochondrial defects prece63%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%
related🧫TFAM and mtDNA analysis in AKI patients63%
related🧫Traumatic Brain Injury and Alzheimer's Disease Relation63%
related🧫DDR factor depletion and focus formation analysis63%
related🧫IRF1 transcriptional regulation of Nlrc5 and Ciita promoters63%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples63%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%
related🧫dilncRNA-mediated molecular crowding and phase separation63%
related🧫Epigenetic clocks association with brain aging patterns in o63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫Sex Differences in Alzheimer's Disease — mechanisms and63%
related🧫Factor depletion effects on DDR focus formation in vivo63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer&#63%
related🧫cGAMP biomarker analysis in ALS patient spinal cord samples63%
related🧫GWAS of plasma pTau217 in East Asian cohort63%
related🧫Longitudinal TLR2 reporter gene study in α-synuclein mice63%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%
related🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P63%
related🧫E2F regulation of endocycles in trophoblast giant cells63%
related🧫BDEV injection and recipient microglial transcriptome analys63%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%
related🧫mtROS effects on TFAM and mtDNA in HK2 cells63%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise63%
related🧫TDP-43 mitochondrial invasion and mtDNA release in iPSC moto63%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫Biomechanical Impact Profiles and Chronic Traumatic Encephal63%
related🧫cGAS/STING pathway activation by TDP-43-released mtDNA63%
related🧫Viral Infections and Alzheimer's Disease — causal mecha63%
related🧫In vitro DDR reconstitution on nucleosomes63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫Proposed experiment from debate on Senolytics targeting p16/63%
related🧫Antiviral Therapy Trial for Parkinson's Disease63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress63%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%
see_also📖ADRA2A Gene60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
see_also📖a2m60%
see_also📖ACVR2A Gene60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
see_also📖ACTB Gene60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
see_also📖ACE Gene60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
see_also📖Aging vs Neurodegeneration: Mechanistic Comparison Matrix60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Cytochrome Therapeutics60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
see_also📖ABCB1 (MDR1) - ATP Binding Cassette Subfamily B Member 160%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
see_also📖Actin Cytoskeleton Dynamics in Neurodegeneration60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
see_also📖ABCD3 Gene60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
see_also📖ABCG1 Gene60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In58%
related🧪SIRT6-NAD+ Axis Enhancement Therapy58%
related🧪PARP1 Inhibition Therapy58%
related🧪Noradrenergic-Tau Propagation Blockade55%
related🧪Circadian-Gated Maresin Biosynthesis Amplification55%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th55%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
mentions🧪Nucleolar Stress Response Normalization50%
mentions🧪R-Loop Resolution Enhancement Therapy50%
mentions🧪Blood-Brain Barrier SPM Shuttle System50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🧪Cryptic Exon Silencing Restoration50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
mentions🧪Nutrient-Sensing Epigenetic Circuit Reactivation50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
related🔬Epigenetic reprogramming in aging neurons50%
mentions🧪Low Complexity Domain Cross-Linking Inhibition50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Lysosomal Calcium Channel Modulation Therapy50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%
mentions🧪Cross-Seeding Prevention Strategy50%
mentions🧪Autophagosome Maturation Checkpoint Control50%
mentions🧪Lysosomal Membrane Repair Enhancement50%
mentions🧪VCP-Mediated Autophagy Enhancement50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧪Arginine Methylation Enhancement Therapy50%
mentions🧪Glycine-Rich Domain Competitive Inhibition50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Transcriptional Autophagy-Lysosome Coupling50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
mentions🧪Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪RNA Granule Nucleation Site Modulation50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
mentions🧪PARP1 Inhibition Therapy50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬What are the mechanisms underlying protein aggregation cross50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪Stress Granule Phase Separation Modulators50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%
mentions🧪Aquaporin-4 Polarization Rescue50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬What gene expression changes in the aging mouse brain predic50%
mentions🧪Netrin-1 Gradient Restoration50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Axonal RNA Transport Reconstitution50%
mentions🧪Perforant Path Presynaptic Terminal Protection Strategy50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
related🔬What are the mechanisms underlying selective vulnerability o50%
mentions🧪Phase-Separated Organelle Targeting50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
mentions🧪Lysosomal Positioning Dynamics Modulation50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
related🧪Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧪KDM6A-Mediated H3K27me3 Rejuvenation50%
mentions🧪HDAC3-Selective Inhibition for Clock Reset50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
mentions🧪FOXO3-Longevity Pathway Epigenetic Reprogramming50%
mentions🧫Gandouling protection against brain injury in Wilson's 44%
mentions🔬What are the mechanisms underlying neuroinflammation resolut40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬What are the mechanisms underlying sleep disruption as cause40%
related🧪Nucleolar Stress Response Normalization40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What are the mechanisms underlying selective vulnerability o40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying perivascular spaces and g40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬What are the mechanisms underlying rna binding protein dysre40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%
related🧪Multi-Modal Stress Response Harmonization40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
related🧪Nucleolar Stress Response Normalization35%
related🧪Multi-Modal Stress Response Harmonization35%

💬 Discussion